Abstract

The first successful implantation of an expandable stent for esophageal cancer was reported in 1990.1 Further experience has shown that self-expanding metallic stents (SEMS) are useful for managing malignant esophageal obstruction.2-5 There is general agreement with regard to their ease of insertion for both operator and patient when compared with rigid plastic endoprostheses. Although the results of an observational study raised a question of whether the complication rate associated with their use is lower than that of plastic stents,6 prospective, randomized trials have suggested a safer profile for SEMS.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call